European Respiratory Review
Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Development of a biomarker for lung inflammation in COPD through analysis of labelled leukocyte transit through the lung circulation
Baker EmmaH., Irwin Andrew, Brennan AmandaL., Trost Brian, Britten Alan, Heenan Sue, Peterson Barry
Eur Respir Rev 2006; 15: 170-171
December 2006 - 15 (101)
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Baker EmmaH., Irwin Andrew, Brennan AmandaL., Trost Brian, Britten Alan, Heenan Sue, Peterson Barry. Development of a biomarker for lung inflammation in COPD through analysis of labelled leukocyte transit through the lung circulation. Eur Respir Rev 2006; 15: 170-171
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Evidence-based eHealth for COPD
Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients
A modified staged treatment algorithm using the AeriSeal System